68462-0158
                        
                    
                            Ondansetron
                        
                    
                                    Ondansetron
                                
                            
                        
                    
                            TABLET, ORALLY DISINTEGRATING
                        
                    
                                    Oral
                                
                            
                        
                    
                                     Ondansetron
                                
                                
                                     8.0
                                
                                
                                     mg/1
                                
                                
                            
                        
                    
                                     68462-0158-11
                                
                                
                                     10 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (68462-158-11) 
                                
                                
                                     June 27, 2007
                                
                                
                                     68462-0158-13
                                
                                
                                     30 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (68462-158-13) 
                                
                                
                                     June 27, 2007
                                
                                
                                    Ancillary Therapy
                                
                            
                        
                    
                                    Antiemetic
                                
                            
                        
                    
                                    5HT3 Receptor Antagonist
                                
                            
                        
                    
                            In Use
                        
                    
 Home